Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma
King of Prussia, Pennsylvania--(Newsfile Corp. - September 14, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that, following the formal completion of the Phase 1b clinical study, it has submitted a meeting request and comprehensive briefing package to the U.S. Food and Drug Administration (FDA).
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-09-14 7:00 AM EDT | Phio Pharmaceuticals Corp.
Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.
Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection with Seraxis's proposal ("Proposed Transaction") to acquire all of the securities of Sernova Biotherapeutics Inc. ("Sernova") pursuant to an arrangement agreement dated September 7, 2026 between Seraxis and Sernova ("Arrangement Agreement"). Pursuant to the Arrangement Agreement, h
2026-09-11 5:40 PM EDT | Dr. Steven S. Sangha
Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
King of Prussia, Pennsylvania--(Newsfile Corp. - September 11, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing therapeutics based on its proprietary INTASYL® siRNA gene-silencing technology designed to eliminate cancer, today announced that members of its management team will be available for one-on-one investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14-16, 2026, at the Lotte Ne
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-09-11 9:00 AM EDT | Phio Pharmaceuticals Corp.
Resverlogix Announces Publication of Scientific Journal Articles Relating to Apabetalone's Prevention of Heart Failure
Calgary, Alberta--(Newsfile Corp. - September 10, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") today announces the publication of two new scientific journal articles on mechanisms relating to heart failure prevention by the Company's lead clinical candidate, apabetalone. "One of the most striking findings from BETonMACE was the reduction in heart failure hospitalizations among apabetalone-treated patients," said Dr. Ewelina Kulikowski, PhD, Chief Scien
Technology, Biotechnology, Healthcare and Hospitals
2026-09-10 7:15 AM EDT | Resverlogix Corp.
medmix' Drug Delivery ("Haselmeier") to Support the Development of Xeris Pharmaceuticals' XP-8121 with D-Flex(TM) Pen Injector
Baar, Switzerland--(Newsfile Corp. - September 10, 2026) - medmix’ Drug Delivery (“Haselmeier”) announces its collaboration with Xeris Pharmaceuticals to support the development of Xeris’ XP-8121 product candidate, an investigational once-weekly subcutaneous levothyroxine therapy in development for the treatment of hypoth
Technology, Construction / Building, Healthcare and Hospitals, Household / Consumer / Cosmetics
2026-09-10 3:06 AM EDT | medmix AG
MD Hyperbaric Appoints Renowned Hyperbaric Researcher Dr. Amir Hadanny as Chief Medical Officer
New York, New York--(Newsfile Corp. - September 9, 2026) - MD Hyperbaric, one of the fastest-growing hyperbaric oxygen therapy (HBOT) networks in the United States, announced the appointment of Amir Hadanny, MD, as Chief Medical Officer. Dr. Hadanny is a neurosurgeon and hyperbaric physician and one of the most published clinical researchers in hyperbaric medicine, with more than 80 peer-reviewed publications. In this role,
Healthcare and Hospitals, Health
2026-09-09 9:00 AM EDT | MD Hyperbaric
LevelJump Announces Management Change
Toronto, Ontario--(Newsfile Corp. - September 9, 2026) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") wishes to announce the appointment of Gus Patel as the Company's interim Chief Financial Officer effective September 1, 2026, replacing Robert Landau. Gus Patel is a finance executive, tax practitioner and licensed public accountant with more than 15 years of experience across public companies, private enterprises and professiona
Healthcare and Hospitals, Health
2026-09-09 8:37 AM EDT | LevelJump Healthcare Corp.
MODUS Structures Acquires ROC Modular, Creating One of Canada's Largest Modular Construction Companies
Crossfield, Alberta--(Newsfile Corp. - September 9, 2026) - MODUS Structures Inc. ("MODUS") today announced that it has completed the acquisition of ROC Modular Inc. ("ROC"), bringing together two established Canadian modular construction businesses. The combined company will operate under the MODUS Structures brand and, based on its workforce, manufacturing footprint and breadth of capabilities, will be one of the largest modular construction companies in Canada. The combination create
Construction / Building, Healthcare and Hospitals, Housing, Aboriginal / Indigenous
2026-09-09 7:00 AM EDT | Modus Structures Inc
WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer
WELL has appointed Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026. Ms. Sutherland brings more than 20 years of senior financial leadership experience, including CFO roles at Staples Canada, Enercare Inc., KEYreit, and United Purchasing Group of Canada (Yum! Brands). Ms. Sutherland has served on the Board of WELL's subsidiary, WELLSTAR, over the past year and brings direct knowledge of the Company's strategy, governance an
Technology, Computer Software, Healthcare and Hospitals, Health
2026-09-09 6:00 AM EDT | WELL Health Technologies Corp.
Discovery Senior Living to Participate in Evercore ISI Healthcare Investment Conference
Bonita Springs, Florida--(Newsfile Corp. - September 8, 2026) - Discovery Senior Living ("Discovery" or "DSL"), one of the one of the largest and most trusted senior housing operators in the U.S., is pleased to announce that Chief Executive Officer Richard Hutchinson will participate in the Evercore ISI Virtual REIT Conference on Wednesday, September 9, 2026.
Healthcare and Hospitals, Real Estate, Housing
2026-09-08 11:33 AM EDT | Discovery Senior Living
Nasdaq Shareholder Requirements Just Verified By Adia Med
Winter Park, Florida--(Newsfile Corp. - September 8, 2026) - Nasdaq requires companies seeking an initial listing on the Nasdaq Capital Market to have a sufficiently broad public shareholder base. That distribution test includes: At least 300 round-lot holders; A round-lot holder generally meaning a shareholder holding at least 100 unrestricted shares; and Adia Med has just verified that it currently has 361 round-lot holders, or
Healthcare and Hospitals, Health
2026-09-08 8:00 AM EDT | Adia Med Inc.
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to be contacted about clinical trials and research studies matched to their health circumstances. HEALWELL's DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Orga
Technology, Computer Software, Healthcare and Hospitals, Health
2026-09-08 6:30 AM EDT | WELL Health Technologies Corp.
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
HEALWELL's DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching trial protocols against the consented patient population. WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to be cont
Technology, Healthcare and Hospitals
2026-09-08 6:30 AM EDT | HEALWELL AI
Kovo+ Announces Forbearance Agreement with Senior Secured Lender and Special Meeting of Shareholders
Calgary, Alberta--(Newsfile Corp. - September 4, 2026) - Kovo+ Holdings Inc. (TSXV: KOVO) ("Kovo" or the "Company") announces that, further to its press releases of August 6, 2026 and August 13, 2026, the Company has entered into a forbearance agreement (the "Forbearance Agreement") with Avonlea Ventures #2 Inc. ("AVI"), Kovo's senior secured lender, pursuant to which AVI has agreed to forbear from exercising, subject to the terms and conditions of the Forbearance
Technology, Healthcare and Hospitals, Internet Technology
2026-09-04 4:41 PM EDT | Kovo+ Holdings Inc.
AVANT and Health In A Box Launch Physician-Led Preventive Health Programs For Club Members
Toronto, Ontario--(Newsfile Corp. - September 3, 2026) - AVANT, the premium private fitness and wellness club, and Health In A Box® today announced a partnership that brings physician-led preventive health programs to AVANT members beginning in mid-September. Members receive biomarker testing, clinical interpretation, and a personalized health action plan built with a clinical team of physicians and naturopathic doctors. Clinical review and follow-up are delivered virtually. AVANT'
Healthcare and Hospitals, Health
2026-09-03 8:00 AM EDT | Health In A Box Inc.
ALZAI Health Corp. Posted for Trading on the Frankfurt Stock Exchange
Toronto, Ontario--(Newsfile Corp. - September 3, 2026) - ALZAI Health Corp. (TSXV: ALZI) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that its common shares are now posted for trading on the Frankfurt Stock Exchange ("FSE") under the symbol H2F. The Frankfurt Stock Exchange is one of Europe's leading securities trading venues, providing access t
Technology, Computer Software, Healthcare and Hospitals
2026-09-03 6:00 AM EDT | Alzai Health Corp.
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, on September 14-16, 2026 at the Lotte New York Palace Hotel in New York City. H.C.
Biotechnology, Healthcare and Hospitals
2026-09-02 8:30 AM EDT | Envoy Medical, Inc.
Veritas Association Management Welcomes International Society for Minimally Invasive Cardiothoracic Surgery to the Veritas Portfolio
Chicago, Illinois--(Newsfile Corp. - September 1, 2026) - Veritas Association Management, a healthcare-focused, AMC Institute accredited association management company, has been selected to provide association management services for the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), a global professional society dedicated to advancing innovation, education and research in minimally invasive cardiac and thoracic surgery.
2026-09-01 10:18 AM EDT | Veritas Association Management
HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange
HEALWELL, through its subsidiary Orion Health, has entered into an agreement with the statewide designated Health Information Exchange of Iowa, Converge Health Iowa, to deploy DARWEN™-powered SMART Search and SMART Summary. The agreement represents a multi-million-dollar, multi-year enterprise opportunity, and is expected to generate recurring revenue over its term that is substantial relative to the current run rate of HEALWELL's A
Technology, Healthcare and Hospitals
2026-09-01 6:00 AM EDT | HEALWELL AI
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team
Winter Park, Florida--(Newsfile Corp. - August 31, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and advanced clinical services, today announced that its introductory innovation session earlier this month at Full Sail University delivered exactly the spark the Company was looking for — and that Adia Med has already assembled a social media team of interns to convert that momentum into a new era of organic marketing.
Healthcare and Hospitals, Health
2026-08-31 8:00 AM EDT | Adia Med Inc.